Journal article
Peripubertal aromatase inhibition in male rats has adverse long-term effects on bone strength and growth and induces prostatic hyperplasia
A Bajpai, PJ Simm, SJ McPherson, VC Russo, WJ Azar, JD Wark, GP Risbridger, GA Werther
Journal of Endocrinology | BIOSCIENTIFICA LTD | Published : 2010
DOI: 10.1677/JOE-10-0006
Abstract
Aromatase inhibitors have been increasingly used in boys with growth retardation to prolong the duration of growth and increase final height. Multiple important roles of oestrogen in males point to potential adverse effects of this strategy. Although the deleterious effects of aromatase deficiency in early childhood and adulthood are well documented, there is limited information about the potential long-term adverse effects of peripubertal aromatase inhibition. To address this issue, we evaluated short-term and long-term effects of peripubertal aromatase inhibition in an animal model. Peripubertal male Wistar rats were treated with aromatase inhibitor letrozole or placebo and followed until ..
View full abstractGrants
Awarded by Pfizer Australia
Awarded by National Health and Medical Research Concil
Funding Acknowledgements
The study was supported by an unrestricted investigator initiated research grant from Pfizer Australia to GAW (AUS-NDE-07-002) and funding from the National Health and Medical Research Concil (545931).